Stocktoria
NEOGENOMICS INC NEO
NEOGENOMICS INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $727.3M | $660.6M | $591.6M | $509.7M | $484.3M | $444.4M | $408.8M | $276.7M | $240.3M | $231.8M |
| Gross profit | $314.3M | $290.1M | $244.6M | $187.9M | $187.1M | $185.9M | $196.8M | $127.3M | $102.0M | $98.1M |
| R&D expense | $37.1M | $31.2M | $27.3M | $30.3M | $21.9M | $8.2M | $8.5M | $3.0M | $3.6M | $4.6M |
| Operating income | -$115.9M | -$92.1M | -$107.7M | -$157.6M | -$118.8M | -$14.0M | $13.0M | $10.0M | $2.9M | $2.2M |
| Interest expense | — | — | $6.9M | $7.6M | $8.2M | $7.0M | $3.7M | $6.2M | $5.5M | — |
| Income tax | -$2.2M | -$1.9M | -$9.1M | -$15.1M | -$6.7M | -$18.2M | -$4.4M | $1.2M | -$2.3M | -$1.7M |
| Net income | -$108.0M | -$78.7M | -$88.0M | -$144.2M | -$8.3M | $4.2M | $8.0M | $2.6M | -$396,000 | -$6.1M |
| Operating cash flow | $5.2M | $7.0M | -$2.0M | -$66.0M | -$26.7M | $1.5M | $23.4M | $44.8M | $18.0M | $21.5M |
| Free cash flow | -$21.8M | -$34.0M | -$30.7M | -$96.9M | -$90.9M | -$27.6M | $3.3M | $30.5M | $4.3M | $13.9M |
| Cash & equivalents | $159.6M | $367.0M | $342.5M | $263.2M | $316.8M | $228.7M | $173.0M | $9.8M | $12.8M | $12.5M |
| Inventory | $28.6M | $26.7M | $24.2M | $24.3M | $23.4M | $29.5M | $14.4M | $8.7M | $7.5M | $6.3M |
| Total assets | $1.4B | $1.6B | $1.7B | $1.7B | $1.9B | $988.3M | $709.5M | $505.0M | $344.5M | $337.1M |
| Total liabilities | $523.3M | $735.7M | $739.7M | $742.0M | $761.5M | $294.0M | $202.1M | $184.6M | $139.9M | $150.5M |
| Shareholders' equity | $836.6M | $902.3M | $941.5M | $998.0M | $1.1B | $694.3M | $507.4M | $320.4M | $172.0M | $162.3M |
Growth · year-over-year · Revenue CAGR 13.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +10.1% | +11.6% | +16.1% | +5.2% | +9.0% | +8.7% | +47.7% | +15.2% | +3.6% | — |
| Net income growth | — | — | — | — | -300.1% | -47.9% | +203.3% | — | — | — |
| Free cash flow growth | — | — | — | — | — | -927.4% | -89.0% | +601.1% | -68.8% | +233.7% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.